These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 20584693)

  • 1. [Correlation between ras gene and the resistance of nasopharyngeal carcinoma to cetuximab].
    Zuo Q; Luo RC
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jun; 30(6):1415-7. PubMed ID: 20584693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of cetuximab-resistant human nasopharyngeal carcinoma cell lines and mechanisms of drug resistance.
    Zuo Q; Shi M; Li L; Chen J; Luo R
    Biomed Pharmacother; 2010 Oct; 64(8):550-8. PubMed ID: 20630698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of silencing H-ras gene by RNA interference on cetuximab-sensitivity of cetuximab-resistant human nasopharyngeal carcinoma cells].
    Zuo Q; Luo RC
    Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):574-8. PubMed ID: 22325215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Ras signaling pathway mediates cetuximab resistance in nasopharyngeal carcinoma.
    Zuo Q; Shi M; Chen J; Liao W
    Biomed Pharmacother; 2011 Jun; 65(3):168-74. PubMed ID: 21602020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relationship between the insulin-like growth factor 1 receptor signaling pathway and the resistance of nasopharyngeal carcinoma to cetuximab].
    Zuo Q; Luo RC
    Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):575-9. PubMed ID: 21122407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Establishment of a human nasopharyngeal carcinoma drug-resistant cell line CNE2/DDP and screening of drug-resistant genes].
    Jiang RD; Zhang LX; Yue W; Zhu YF; Lu HJ; Liu X; Cen XT; Guan XY; Li CH
    Ai Zheng; 2003 Apr; 22(4):337-45. PubMed ID: 12703984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear Klf4 accumulation is associated with cetuximab drug-resistance and predicts poor prognosis of nasopharyngeal carcinoma.
    Li X; Zhao Z; Yi S; Ma L; Li M; Liu M; Zhang Y; Liu G
    J Transl Med; 2018 Jul; 16(1):183. PubMed ID: 29973197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacoproteomics study of cetuximab in nasopharyngeal carcinoma.
    Sung FL; Pang RT; Ma BB; Lee MM; Chow SM; Poon TC; Chan AT
    J Proteome Res; 2006 Dec; 5(12):3260-7. PubMed ID: 17137327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Differentially expressed gene in nasopharyngeal carcinoma cell lines with various metastatic potentialities].
    Zhang L; Song L; Ma Y; Huang B; Liang Q; Zeng Y
    Zhonghua Zhong Liu Za Zhi; 2002 Sep; 24(5):430-4. PubMed ID: 12485491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab.
    Khambata-Ford S; Garrett CR; Meropol NJ; Basik M; Harbison CT; Wu S; Wong TW; Huang X; Takimoto CH; Godwin AK; Tan BR; Krishnamurthi SS; Burris HA; Poplin EA; Hidalgo M; Baselga J; Clark EA; Mauro DJ
    J Clin Oncol; 2007 Aug; 25(22):3230-7. PubMed ID: 17664471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor 9 agonist IMO cooperates with cetuximab in K-ras mutant colorectal and pancreatic cancers.
    Rosa R; Melisi D; Damiano V; Bianco R; Garofalo S; Gelardi T; Agrawal S; Di Nicolantonio F; Scarpa A; Bardelli A; Tortora G
    Clin Cancer Res; 2011 Oct; 17(20):6531-41. PubMed ID: 21890455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Establishment of a nude mouse model of nasopharyngeal carcinoma lymph node metastasis and screening of the metastasis-related signature genes].
    Leng L; Liu TF; Huang ZX; Xie WB; Yao KT
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1519-22. PubMed ID: 18819858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. K-ras mutations and benefit from cetuximab in advanced colorectal cancer.
    Karapetis CS; Khambata-Ford S; Jonker DJ; O'Callaghan CJ; Tu D; Tebbutt NC; Simes RJ; Chalchal H; Shapiro JD; Robitaille S; Price TJ; Shepherd L; Au HJ; Langer C; Moore MJ; Zalcberg JR
    N Engl J Med; 2008 Oct; 359(17):1757-65. PubMed ID: 18946061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amplification of chromosome 8q21-qter associated with the acquired paclitaxel resistance of nasopharyngeal carcinoma cells.
    Li W; You Y; Zhang X; Song Y; Xiang H; Peng X; Qin J; Tan G
    Int J Clin Exp Pathol; 2015; 8(10):12346-56. PubMed ID: 26722421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity to epidermal growth factor receptor inhibitor requires E-cadherin expression in urothelial carcinoma cells.
    Black PC; Brown GA; Inamoto T; Shrader M; Arora A; Siefker-Radtke AO; Adam L; Theodorescu D; Wu X; Munsell MF; Bar-Eli M; McConkey DJ; Dinney CP
    Clin Cancer Res; 2008 Mar; 14(5):1478-86. PubMed ID: 18316572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of multidrug resistance gene in nasopharyngeal carcinoma cells after irradiation exposure].
    Bu JG; Yuan YW; Chen J
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Jun; 24(6):646-9. PubMed ID: 15201079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiling and comparing transcription factors activated in non-metastatic and metastatic nasopharyngeal carcinoma cells.
    Su B; Xiang B; Wang L; Cao L; Xiao L; Li X; Li X; Wu M; Li G
    J Cell Biochem; 2010 Jan; 109(1):173-83. PubMed ID: 19911387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ras mutations and expression in head and neck squamous cell carcinomas.
    Yarbrough WG; Shores C; Witsell DL; Weissler MC; Fidler ME; Gilmer TM
    Laryngoscope; 1994 Nov; 104(11 Pt 1):1337-47. PubMed ID: 7968162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ras mutational status is a biomarker for resistance to EGFR inhibitors in colorectal carcinoma.
    Dempke WC; Heinemann V
    Anticancer Res; 2010 Nov; 30(11):4673-7. PubMed ID: 21115922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis.
    Qian J; Niu J; Li M; Chiao PJ; Tsao MS
    Cancer Res; 2005 Jun; 65(12):5045-53. PubMed ID: 15958547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.